• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部病情加重后恢复不佳不会导致第一秒用力呼气容积加速下降。

Poor recovery from a pulmonary exacerbation does not lead to accelerated FEV decline.

作者信息

Sanders Don B, Li Zhanhai, Zhao Qianqian, Farrell Philip M

机构信息

Department of Pediatrics, Riley Hospital for Children, School of Medicine, Indiana University, Indiana, IN, USA.

Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

出版信息

J Cyst Fibros. 2017 Jul 29. doi: 10.1016/j.jcf.2017.07.003.

DOI:10.1016/j.jcf.2017.07.003
PMID:28765072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788732/
Abstract

BACKGROUND

Patients with CF treated for pulmonary exacerbations (PEx) may experience faster subsequent declines in FEV. Additionally, incomplete recovery to baseline FEV occurs frequently following PEx treatment. Whether accelerated declines in FEV are preceded by poor PEx recovery has not been studied.

METHODS

Using 2004 to 2011 CF Foundation Patient Registry data, we randomly selected one PEx among patients ≥6years of age with no organ transplantations, ≥12months of data before and after the PEx, and ≥1 FEV recorded within the 6months before and 3months after the PEx. We defined poor PEx recovery as the best FEV in the 3months after the PEx <90% of the best FEV in the 6months before the PEx. We calculated mean (95% CI) hazard ratios (HR) of having >5% predicted/year FEV decline and poor PEx recovery using multi-state Markov models.

RESULTS

From 13,954 PEx, FEV declines of >5% predicted/year were more likely to precede poor spirometric recovery, HR 1.17 (1.08, 1.26), in Markov models adjusted for age and sex. Non-Responders were less likely to have a subsequent fast FEV decline, HR 0.41 (0.37, 0.46), than patients who recovered to >90% of baseline FEV following PEx treatment.

CONCLUSIONS

Accelerated declines in FEV are more likely to precede a PEx with poor recovery than to occur in the following year. Preventing or halting declines in FEV may also have the benefit of preventing PEx episodes.

摘要

背景

接受肺部加重期(PEx)治疗的囊性纤维化(CF)患者,其后续的第一秒用力呼气容积(FEV)可能会更快下降。此外,PEx治疗后FEV经常无法完全恢复到基线水平。FEV加速下降是否先于PEx恢复不佳尚未得到研究。

方法

利用2004年至2011年CF基金会患者注册数据,我们在≥6岁、未接受器官移植、PEx前后有≥12个月数据且PEx前6个月和后3个月内记录有≥1次FEV的患者中随机选择一次PEx。我们将PEx恢复不佳定义为PEx后3个月内的最佳FEV < PEx前6个月内最佳FEV的90%。我们使用多状态马尔可夫模型计算预测每年FEV下降>5%和PEx恢复不佳的平均(95%置信区间)风险比(HR)。

结果

在13954次PEx中,在根据年龄和性别调整的马尔可夫模型中,预测每年FEV下降>5%更有可能先于肺功能恢复不佳,HR为1.17(1.08,1.26)。与PEx治疗后恢复到基线FEV的>90%的患者相比,无反应者随后FEV快速下降的可能性较小,HR为0.41(0.37,0.46)。

结论

FEV加速下降更有可能先于恢复不佳的PEx出现,而不是在次年发生。预防或阻止FEV下降也可能有助于预防PEx发作。

相似文献

1
Poor recovery from a pulmonary exacerbation does not lead to accelerated FEV decline.肺部病情加重后恢复不佳不会导致第一秒用力呼气容积加速下降。
J Cyst Fibros. 2017 Jul 29. doi: 10.1016/j.jcf.2017.07.003.
2
Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes.囊性纤维化肺部加重期恢复不佳与长期预后不良相关。
Pediatr Pulmonol. 2017 Oct;52(10):1268-1275. doi: 10.1002/ppul.23765. Epub 2017 Sep 7.
3
Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations.重新审视静脉治疗后肺部恶化的基础肺功能恢复情况。
J Cyst Fibros. 2023 Sep;22(5):864-867. doi: 10.1016/j.jcf.2023.02.006. Epub 2023 Feb 16.
4
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.标准化治疗肺部加重(STOP)研究:囊性纤维化肺部加重静脉内抗生素治疗开始时的观察。
J Cyst Fibros. 2017 Sep;16(5):592-599. doi: 10.1016/j.jcf.2017.04.005. Epub 2017 Apr 29.
5
Antibiotic duration and changes in FEV are not associated with time until next exacerbation in adult cystic fibrosis: a single center study.抗生素疗程和 FEV 变化与成人囊性纤维化下一次加重的时间无关:一项单中心研究。
BMC Pulm Med. 2017 Nov 29;17(1):160. doi: 10.1186/s12890-017-0503-6.
6
Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations.支气管扩张剂对囊性纤维化儿童肺部加重期治疗的反应性。
Pediatr Pulmonol. 2021 Jul;56(7):2036-2042. doi: 10.1002/ppul.25409. Epub 2021 Apr 20.
7
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.肺功能在囊性纤维化肺部感染加重抗菌治疗前后的变化。
Pediatr Pulmonol. 2020 Mar;55(3):828-834. doi: 10.1002/ppul.24577. Epub 2019 Nov 20.
8
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
9
Exploring the Relationship between FEV Loss and Recovery and Aminoglycoside Pharmacokinetics in Adult Patients with Cystic Fibrosis: Implications for Clinical Dosing Strategies.探讨成人囊性纤维化患者 FEV 损失与恢复和氨基糖苷类药代动力学之间的关系:对临床给药策略的影响。
Pharmacotherapy. 2020 Jun;40(6):584-591. doi: 10.1002/phar.2399. Epub 2020 May 5.
10
Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis.囊性纤维化患者的肺部恶化和肺功能急性下降。
J Cyst Fibros. 2018 Jul;17(4):496-502. doi: 10.1016/j.jcf.2018.02.003. Epub 2018 Apr 21.

引用本文的文献

1
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.囊性纤维化患者的急性肺部恶化表型。
Ann Am Thorac Soc. 2022 Nov;19(11):1818-1826. doi: 10.1513/AnnalsATS.202111-1266OC.

本文引用的文献

1
Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function Decline.患有囊性纤维化且携带G551D或纯合F508del突变的患者:肺功能下降情况相似。
Am J Respir Crit Care Med. 2017 Jun 15;195(12):1673-1676. doi: 10.1164/rccm.201608-1678LE.
2
Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis.影响囊性纤维化患者下次肺部病情加重时间的治疗及人口统计学因素。
J Cyst Fibros. 2015 Nov;14(6):763-9. doi: 10.1016/j.jcf.2015.02.007. Epub 2015 Mar 6.
3
Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
囊性纤维化肺部加重期治疗对全身炎症的影响。
Ann Am Thorac Soc. 2015 May;12(5):708-17. doi: 10.1513/AnnalsATS.201410-493OC.
4
Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.与囊性纤维化患者肺部感染治疗反应相关的因素。
J Cyst Fibros. 2015 Nov;14(6):755-62. doi: 10.1016/j.jcf.2015.01.007. Epub 2015 Feb 14.
5
A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.半参数方法估计囊性纤维化患者的肺功能快速下降。
Ann Epidemiol. 2013 Dec;23(12):771-7. doi: 10.1016/j.annepidem.2013.08.009. Epub 2013 Oct 5.
6
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.在囊性纤维化肺部恶化期间的炎症和气道微生物群。
PLoS One. 2013 Apr 30;8(4):e62917. doi: 10.1371/journal.pone.0062917. Print 2013.
7
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.治疗囊性纤维化肺部恶化的口服、吸入和静脉用抗生素选择。
Pediatr Pulmonol. 2013 Jul;48(7):666-73. doi: 10.1002/ppul.22652. Epub 2012 Aug 8.
8
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.成人囊性纤维化患者 1 秒率下降率的风险因素。
J Cyst Fibros. 2012 Sep;11(5):405-11. doi: 10.1016/j.jcf.2012.03.009. Epub 2012 May 5.
9
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.肺脏恶化对囊性纤维化患者长期肺功能下降的影响。
Eur Respir J. 2012 Jul;40(1):61-6. doi: 10.1183/09031936.00159111. Epub 2011 Dec 1.
10
Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa.慢性铜绿假单胞菌感染囊性纤维化患者肺部恶化治疗失败的发生率和危险因素。
Chest. 2012 Feb;141(2):485-493. doi: 10.1378/chest.11-0917. Epub 2011 Aug 11.